Inactivation of GSK-3β phosphorylation resulted in nuclear localization of β-catenin, which leads to the activation of GSK/β-catenin signaling pathway and promotes tumor metastasis (Yu et al., 2014). The gene discussed is GSK3B; the disease is neoplasm.